Eman Soliman
Impact in
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
- Inflammatory mediators and NSAID effects
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
-
- Cannabis and Cannabinoid Research 5
- Co-authors
- Rukiyah Van Dross (11 shared papers)Shimaa M. Elshazly (6 shared papers)Daniel A. Ladin (3 shared papers)LaToya M. Griffin (1 shared paper)Amr A. A. Mahmoud (2 shared papers)Mona F. Mahmoud (2 shared papers)Allison S. Danell (2 shared papers)Nabila N. El‐Maraghy (1 shared paper)
- Journals
- Molecular Carcinogenesis (2 papers)Journal of Neuroinflammation (2 papers)Frontiers in Pharmacology (2 papers)Frontiers in Molecular Neuroscience (2 papers)Life Sciences (2 papers)
- Partner nations
- EgyptUnited StatesOman
In The Last Decade
Eman Soliman
44 papers receiving 805 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 265
- Biological Psychiatry 33
- Neurology 58
- Immunology 101
- Toxicology 15
Countries citing papers authored by Eman Soliman
This map shows the geographic impact of Eman Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman Soliman more than expected).
Fields of papers citing papers by Eman Soliman
This network shows the impact of papers produced by Eman Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman Soliman. The network helps show where Eman Soliman may publish in the future.
Co-authors
The 25 scholars most cited alongside Eman Soliman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 81 | |
| 2 | 2015 | 53 | |
| 3 | 2019 | 53 | |
| 4 | 2015 | 49 | |
| 5 | 2015 | 47 | |
| 6 | 2018 | 46 | |
| 7 | 2021 | 46 | |
| 8 | 2017 | 39 | |
| 9 | 2022 | 37 | |
| 10 | 2020 | 33 | |
| 11 | 2020 | 25 | |
| 12 | 2012 | 25 | |
| 13 | 2020 | 22 | |
| 14 | 2020 | 21 | |
| 15 | 2020 | 20 | |
| 16 | 2023 | 19 | |
| 17 | 2019 | 18 | |
| 18 | 2017 | 16 | |
| 19 | 2019 | 15 | |
| 20 | 2023 | 13 |
About Eman Soliman
Eman Soliman is a scholar working on Molecular Biology, Pharmacology, Neurology, Agronomy and Crop Science and Immunology, having authored 45 papers that have together received 816 indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Animal Disease Management and Epidemiology (6 papers), Cannabis and Cannabinoid Research (5 papers), Viral Infections and Immunology Research (5 papers), Vector-Borne Animal Diseases (4 papers), GABA and Rice Research (3 papers), Immune cells in cancer (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Pharmacology (265 citations), Biological Psychiatry (33 citations), Neurology (58 citations), Immunology (101 citations) and Toxicology (15 citations). Eman Soliman has collaborated with scholars based in Egypt, United States and Oman. Frequent co-authors include Rukiyah Van Dross, Shimaa M. Elshazly, Daniel A. Ladin, LaToya M. Griffin, Amr A. A. Mahmoud, Mona F. Mahmoud, Allison S. Danell, Nabila N. El‐Maraghy, Ken Soderstrom and Audrey Jenkins. Their work appears in journals such as Molecular Carcinogenesis, Journal of Neuroinflammation, Frontiers in Pharmacology, Frontiers in Molecular Neuroscience and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.